MedPath
TGA Approval

AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector (273536)

273536

AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector

Amgen Australia Pty Ltd

November 9, 2017

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/34051bb93ae1aa1415176fd8b58bdf5d.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/c4e60db6aecdd22e4f1640c7818ddaec.pdf

Active Ingredients

Adalimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector (273536) - TGA 批准文号 | MedPath